Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase

Regulatory obstacles unlikely for Ebos' A$1.17b LifeHealthcare purchase
Ebos CEO John Cullity doesn't want to pre-empt regulators. (Image: supplied)
Jenny Ruth
Ebos Group's purchase of the LifeHealthcare business is unlikely to have trouble clearing competition watchdogs on either side of the Tasman since its existing medical devices business is quite small.Ebos bought the LMT and National Surgical businesses in late 2019 for A$34 million compared with the LifeHealthcare purchase price of A$1.17 billion.In August last year, it also announced the purchase of Pioneer Medical, a New Zealand-based importer and distributor of spine and major joint implants and associated surgical technologies.Ebos didn...

More Infrastructure

Court funding miss ‘undermines market confidence’
Finance

Court funding miss ‘undermines market confidence’

Plenary and Infrastructure NZ wrote to ministers over PPP ‘disappointment’.

Oliver Lewis 17 Sep 2025
The 'little thing' Infratil brings to its investments
Infrastructure

The 'little thing' Infratil brings to its investments

CEOs may not like it, but the returns are undeniable.

Auckland housing project withdrawn from fast-track
Policy

Auckland housing project withdrawn from fast-track

The developer plans to lodge a fresh application after draft decline.

Oliver Lewis 16 Sep 2025
150 years of infrastructure spending going ‘boom’
Infrastructure

150 years of infrastructure spending going ‘boom’

We actually spend a lot more on infrastructure than you might think.